Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
Diurno F, Numis FG, Porta G, Cirillo F, Maddaluno S, Ragozzino A, De Negri P, Di Gennaro C, Pagano A, Allegorico E, Bressy L, Bosso G, Ferrara A, Serra C, Montisci A, D'Amico M, Schiano Lo Morello S, Di Costanzo G, Tucci AG, Marchetti P, Di Vincenzo U, Sorrentino I, Casciotta A, Fusco M, Buonerba C, Berretta M, Ceccarelli M, Nunnari G, Diessa Y, Cicala S, Facchini G. Diurno F, et al. Among authors: diessa y. Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047. doi: 10.26355/eurrev_202004_20875. Eur Rev Med Pharmacol Sci. 2020. PMID: 32329881 Free article.
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.
Franzese E, Falco S, Laterza MM, Montella L, Facchini S, Liguori C, Coppola P, Diessa Y, Berretta M, Pisconti S, Trama F, Ferro M, Crocetto F, Fasano M, Buonerba C, Facchini G. Franzese E, et al. Among authors: diessa y. Future Sci OA. 2021 Apr 7;7(6):FSO705. doi: 10.2144/fsoa-2021-0035. Future Sci OA. 2021. PMID: 34046207 Free PMC article. No abstract available.
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting.
D'Aniello C, Cavaliere C, Foglia C, Facchini S, Uricchio F, Balsamo R, Franzese E, De Falco S, Izzo M, Laterza M, Liguori C, Coppola P, Diessa Y, Fasano M, Di Lauro G, Lai S, Cocetta V, Pisconti S, Montesarchio V, Facchini G. D'Aniello C, et al. Among authors: diessa y. Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8481-8501. doi: 10.26355/eurrev_202211_30384. Eur Rev Med Pharmacol Sci. 2022. PMID: 36459030 Free article. Review.